Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
fMRI/EEG of Nicotine Lozenge in Nicotine Withdrawal
NCT00657020Phase 4Completed
- Sponsor
- GSK
- Start
- Sep 2007
- Primary completion
- Feb 2008
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, double-blind trial in Nicotine withdrawal comparing Nicotine lozenge with Placebo lozenge (2 arms). Primary endpoint: Percent Mean Change in Blood Oxygen-level Dependent (BOLD) Scores During Rapid Visual Information Processing (RVIP) Task. Started Sep 2007; status: completed.
02
Drugs
nicotine
03
Conditions
Nicotine withdrawal
Beyond the preview
Go deeper on NCT00657020.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00657020.